# Acne Vulgaris trials recruiting, no drug phase: 23 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with no drug phase for Acne Vulgaris that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Acne Vulgaris trials with no drug phase: 23 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/acne-vulgaris

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 23
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946250 | A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or... | BrocShot Inc | Not applicable | Not yet recruiting | Reactive Skin, Blemish-Prone Skin, Hormonally Affected Skin, Acne, Rosacea, Eczema, Psoriasis, Skin Irritation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946250) |
| November 18, 2026 | NCT07944274 | Active Versus Vehicle Home Care During PRX S Treatment for Mild-to-Moderate Facial Acne | Medical University of Silesia | Not applicable | Not yet recruiting | Acne Vulgaris | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944274) |
| November 17, 2026 | NCT07941440 | Clinical Outcomes of PRX S With Standardized Home Care in Mild-to-Moderate Facial Acne. | Medical University of Silesia | Not applicable | Not yet recruiting | Acne Vulgaris | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941440) |
| October 27, 2026 | NCT07896486 | Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation | Weill Medical College of Cornell University | Not applicable | Recruiting | Post-inflammatory Hyperpigmentation, Post-acne Hyperpigmentation | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896486) |
| October 20, 2026 | NCT07883538 | Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris | Pak Emirates Military Hospital | Not applicable | Recruiting | Acne Vulgaris | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883538) |
| September 4, 2026 | NCT07805655 | Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris | Jeisys Medical Inc | Not applicable | Recruiting | Acne Vulgaris | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805655) |
| August 6, 2026 | NCT07749469 | Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin | USMARI Research & Innovation Centre | Not applicable | Recruiting | Acne | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749469) |
| April 24, 2026 | NCT07549828 | Sebum Metabolomics and Lipidomics for Clinical Applications | National Taiwan University Hospital | Not applicable | Not yet recruiting | Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, Healthy Subjects (HS) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07549828) |
| April 20, 2026 | NCT07539129 | Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic... | Foundation University Islamabad | Not applicable | Not yet recruiting | Acne Vulgaris | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07539129) |
| March 18, 2026 | NCT07481019 | A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology | National University Hospital, Singapore | Not applicable | Not yet recruiting | Chronic Dermatological Conditions, Eczema, Urticaria, Psoriasis, Acne | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07481019) |
| February 19, 2026 | NCT07421804 | Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin... | Assiut University | Not applicable | Not yet recruiting | Acne Vulgaris | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421804) |
| January 14, 2026 | NCT07341087 | Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial | King's College London | Not applicable | Recruiting | Skin Inflammation, Immunosenescence, Inflammation, Skin Health, Eczema, Rosacea, Acne, Menopause | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341087) |
| August 17, 2025 | NCT07127523 | A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy... | GenCanna Acquisition Corp | Not applicable | Not yet recruiting | Acne | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07127523) |
| July 28, 2025 | NCT07089368 | Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe... | Università degli Studi di Brescia | Not applicable | Not yet recruiting | Acne | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07089368) |
| July 14, 2025 | NCT07062081 | Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate | Sohag University | Not applicable | Not yet recruiting | Acne Vulgaris | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07062081) |
| July 9, 2025 | NCT07056673 | Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study | Shenyang Medical College | Not applicable | Recruiting | Acne Vulgaris | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07056673) |
| July 8, 2025 | NCT07054398 | Assessment of Serum Catestatin Level in Acne Vulgaris Patients | Aswan University | Not applicable | Recruiting | Acne Vulgaris | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07054398) |
| March 11, 2025 | NCT06868615 | AVAVA MIRIA General Use | AVAVA, Inc. | Not applicable | Recruiting | Acne, Acne Scars - Mixed Atrophic and Hypertrophic, Scars, Wrinkle, Pigment; Lesion, Skin Texture Disorder | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06868615) |
| January 8, 2025 | NCT06763367 | Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis | Nanjing First Hospital, Nanjing Medical University | Not applicable | Not yet recruiting | Rosacea, Acne, Centella, Melasma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06763367) |
| December 11, 2024 | NCT06729450 | Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris | Kane Biotech Inc | Not applicable | Not yet recruiting | Acne Vulgaris on the Face | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06729450) |
| December 10, 2024 | NCT06725303 | Excimer Light Versus Blue Light in Acne | Cairo University | Not applicable | Not yet recruiting | Acne Vulgaris | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06725303) |
| December 4, 2024 | NCT06716398 | A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase | Pierre Fabre Dermo Cosmetique | Not applicable | Recruiting | Acne | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06716398) |
| September 19, 2024 | NCT06590909 | Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acne Scars | Assiut University | Not applicable | Not yet recruiting | Acne Vulgaris | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06590909) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Medical University of Silesia | 2 |
| Assiut University | 2 |
| GenCanna Acquisition Corp | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| King's College London | 1 |
| Kane Biotech Inc | 1 |
| Foundation University Islamabad | 1 |
| Weill Medical College of Cornell University | 1 |
| BrocShot Inc | 1 |
| National University Hospital, Singapore | 1 |
| Sohag University | 1 |
| Aswan University | 1 |
| Pak Emirates Military Hospital | 1 |
| Shenyang Medical College | 1 |
| [Pierre Fabre Dermo Cosmetique](https://specstream.ai/data/clinical-trials/company/pierre-fabre-dermo-cosmetique) | 1 |
| AVAVA, Inc. | 1 |
| Jeisys Medical Inc | 1 |
| Università degli Studi di Brescia | 1 |
| Cairo University | 1 |
| National Taiwan University Hospital | 1 |
| USMARI Research & Innovation Centre | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 4 |
| China | 2 |
| Poland | 2 |
| Pakistan | 2 |
| Egypt | 2 |
| Canada | 1 |
| United Kingdom | 1 |
| Brazil | 1 |
| Mexico | 1 |
| Malaysia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Grout companies in the United States](https://specstream.ai/data/businesses/grout-companies/united-states)
- [B2B outdoor advertising companies in the United States](https://specstream.ai/data/businesses/b2b-outdoor-advertising-companies/united-states)
- [Product design firms in the United States](https://specstream.ai/data/businesses/product-design-firms/united-states)
- [Furniture manufacturers in the United States](https://specstream.ai/data/businesses/furniture-manufacturers/united-states)
- [Ayurveda clinics in the United States](https://specstream.ai/data/businesses/ayurveda-clinics/united-states)
